Siemens Healthineers (ETR:SHL) has been assigned a €54.40 ($64.00) price objective by research analysts at JPMorgan Chase & Co. in a research note issued to investors on Tuesday, Borsen Zeitung reports. JPMorgan Chase & Co.‘s price target suggests a potential downside of 0.15% from the stock’s current price.
Several other analysts have also recently commented on SHL. Independent Research set a €51.00 ($60.00) price target on shares of Siemens Healthineers and gave the stock a “neutral” rating in a research note on Tuesday, May 4th. Deutsche Bank Aktiengesellschaft set a €56.00 ($65.88) price target on shares of Siemens Healthineers and gave the stock a “buy” rating in a research note on Tuesday, May 4th. Kepler Capital Markets set a €54.00 ($63.53) price target on shares of Siemens Healthineers and gave the stock a “buy” rating in a research note on Thursday, June 17th. DZ Bank restated a “neutral” rating on shares of Siemens Healthineers in a research report on Friday, June 25th. Finally, Berenberg Bank set a €56.00 ($65.88) target price on shares of Siemens Healthineers and gave the company a “buy” rating in a research report on Thursday, April 29th. Five analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of €51.73 ($60.86).
Shares of SHL stock opened at €54.48 ($64.09) on Tuesday. The stock has a market cap of $61.40 billion and a PE ratio of 36.22. Siemens Healthineers has a 52 week low of €35.58 ($41.85) and a 52 week high of €54.52 ($64.14). The company has a debt-to-equity ratio of 98.67, a quick ratio of 2.26 and a current ratio of 2.60. The business has a fifty day moving average of €49.84.
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, diagnostic, and advanced therapies products and services to healthcare providers worldwide. The company operates through three segments; Imaging, Diagnostics, and Advanced Therapies. The Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems.
See Also: What is a Secondary Public Offering?
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.